XML 116 R105.htm IDEA: XBRL DOCUMENT v3.7.0.1
Guarantor Financial Information (Consolidating Statements of Income) (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Revenues:        
Product sales $ 3,591.8 $ 2,322.1 $ 7,004.1 $ 3,949.4
Royalties and other revenues 154.0 107.0 314.0 189.0
Total revenues 3,745.8 2,429.1 7,318.1 4,138.4
Costs and expenses:        
Cost of sales 1,108.9 778.1 2,435.9 1,026.7
Research and development 542.4 294.8 921.7 511.9
Selling, general and administrative 899.1 675.3 1,788.0 1,150.2
Amortization of acquired intangible assets 434.1 213.0 798.1 347.6
Integration and acquisition costs 343.7 363.0 459.7 454.1
Reorganization costs 13.6 11.0 19.1 14.3
Gain/(loss) on sale of product rights (4.8) 2.3 0.7 6.5
Total operating expenses 3,346.6 2,332.9 6,421.8 3,498.3
Operating income from continuing operations 399.2 96.2 896.3 640.1
Interest (expense)/income, net (140.2) (85.6) (279.4) (129.3)
Other income/(expense), net 2.5 6.0 7.0 (2.5)
Total other expense, net (137.7) (79.6) (272.4) (131.8)
Income from continuing operations before income taxes and equity in earnings/(losses) of equity method investees 261.5 16.6 623.9 508.3
Income taxes (24.3) 70.9 (31.1) (11.2)
Equity in income/(losses) of equity method investees, net of taxes 4.3 (0.9) 3.5 (1.0)
Income from continuing operations, net of taxes 241.5 86.6 596.3 496.1
(Loss)/gain from discontinued operations, net of taxes (1.2) (248.7) 19.0 (239.2)
Net income/(loss) 240.3 (162.1) 615.3 256.9
Comprehensive income/(loss) 1,667.5 (388.5) 2,313.0 54.9
Eliminations        
Revenues:        
Product sales 0.0 0.0 0.0 0.0
Royalties and other revenues 0.0 0.0 0.0 0.0
Total revenues 0.0 0.0 0.0 0.0
Costs and expenses:        
Cost of sales 0.0 0.0 0.0 0.0
Research and development 0.0 0.0 0.0 0.0
Selling, general and administrative 0.0 0.0 0.0 0.0
Amortization of acquired intangible assets 0.0 0.0 0.0 0.0
Integration and acquisition costs 0.0 0.0 0.0 0.0
Reorganization costs 0.0 0.0 0.0 0.0
Gain/(loss) on sale of product rights 0.0 0.0 0.0 0.0
Total operating expenses 0.0 0.0 0.0 0.0
Operating income from continuing operations 0.0 0.0 0.0 0.0
Interest (expense)/income, net 0.0 0.0 0.0 0.0
Other income/(expense), net 0.0 0.0 0.0 0.0
Total other expense, net 0.0 0.0 0.0 0.0
Income from continuing operations before income taxes and equity in earnings/(losses) of equity method investees 0.0 0.0 0.0 0.0
Income taxes 0.0 0.0 0.0 0.0
Equity in income/(losses) of equity method investees, net of taxes (525.7) 253.7 (816.7) (203.5)
Income from continuing operations, net of taxes (525.7) 253.7 (816.7) (203.5)
(Loss)/gain from discontinued operations, net of taxes 0.0 0.0 0.0 0.0
Net income/(loss) (525.7) 253.7 (816.7) (203.5)
Comprehensive income/(loss) (3,328.0) 665.5 (4,134.8) 184.8
Shire plc (Parent Guarantor)        
Revenues:        
Product sales 0.0 0.0 0.0 0.0
Royalties and other revenues 0.0 0.0 0.0 0.0
Total revenues 0.0 0.0 0.0 0.0
Costs and expenses:        
Cost of sales 0.0 0.0 0.0 0.0
Research and development 0.0 0.0 0.0 0.0
Selling, general and administrative 8.7 18.8 18.1 35.8
Amortization of acquired intangible assets 0.0 0.0 0.0 0.0
Integration and acquisition costs 160.1 164.7 0.0
Reorganization costs 0.0 0.0 0.0 0.0
Gain/(loss) on sale of product rights 0.0 0.0 0.0 0.0
Total operating expenses 168.8 18.8 182.8 35.8
Operating income from continuing operations (168.8) (18.8) (182.8) (35.8)
Interest (expense)/income, net (30.8) (22.6) (61.1) (44.5)
Other income/(expense), net 1.8 1.2 1.8 0.9
Total other expense, net (29.0) (21.4) (59.3) (43.6)
Income from continuing operations before income taxes and equity in earnings/(losses) of equity method investees (197.8) (40.2) (242.1) (79.4)
Income taxes (0.7) 0.9 0.8 1.9
Equity in income/(losses) of equity method investees, net of taxes 438.8 (122.8) 856.6 334.4
Income from continuing operations, net of taxes 240.3 (162.1) 615.3 256.9
(Loss)/gain from discontinued operations, net of taxes 0.0 0.0 0.0 0.0
Net income/(loss) 240.3 (162.1) 615.3 256.9
Comprehensive income/(loss) 1,667.5 (388.5) 2,313.0 54.9
SAIIDAC (SAIIDAC Notes Subsidiary Issuer)        
Revenues:        
Product sales 0.0 0.0 0.0 0.0
Royalties and other revenues 0.0 0.0 0.0 0.0
Total revenues 0.0 0.0 0.0 0.0
Costs and expenses:        
Cost of sales 0.0 0.0 0.0 0.0
Research and development 0.0 0.0 0.0 0.0
Selling, general and administrative 0.0 0.0 0.0 0.0
Amortization of acquired intangible assets 0.0 0.0 0.0 0.0
Integration and acquisition costs 0.0 0.0 0.0 0.0
Reorganization costs 0.0 0.0 0.0 0.0
Gain/(loss) on sale of product rights 0.0 0.0 0.0 0.0
Total operating expenses 0.0 0.0 0.0 0.0
Operating income from continuing operations 0.0 0.0 0.0 0.0
Interest (expense)/income, net 6.1 1.6 11.5 (20.2)
Other income/(expense), net 0.0 0.0 0.0 0.0
Total other expense, net 6.1 1.6 11.5 (20.2)
Income from continuing operations before income taxes and equity in earnings/(losses) of equity method investees 6.1 1.6 11.5 (20.2)
Income taxes (2.9) (0.4) (4.2) 5.1
Equity in income/(losses) of equity method investees, net of taxes 0.0 0.0 0.0 0.0
Income from continuing operations, net of taxes 3.2 1.2 7.3 (15.1)
(Loss)/gain from discontinued operations, net of taxes 0.0 0.0 0.0 0.0
Net income/(loss) 3.2 1.2 7.3 (15.1)
Comprehensive income/(loss) 3.2 1.2 7.3 (15.1)
Baxalta Inc. (Baxalta Notes Subsidiary Issuer and SAIIDAC Notes Subsidiary Guarantor)        
Revenues:        
Product sales 0.0 0.0 0.0 0.0
Royalties and other revenues 0.0 0.0 0.0 0.0
Total revenues 0.0 0.0 0.0 0.0
Costs and expenses:        
Cost of sales 0.2 0.0 1.4 0.0
Research and development 0.0 0.0 0.0 0.0
Selling, general and administrative 4.2 6.9 9.9 6.9
Amortization of acquired intangible assets 0.0 0.0 0.0 0.0
Integration and acquisition costs 17.5 211.8 43.1 211.8
Reorganization costs 0.0 0.0 0.0 0.0
Gain/(loss) on sale of product rights 0.0 0.0 0.0 0.0
Total operating expenses 21.9 218.7 54.4 218.7
Operating income from continuing operations (21.9) (218.7) (54.4) (218.7)
Interest (expense)/income, net (21.5) (6.3) (42.9) (6.3)
Other income/(expense), net (0.6) 7.7 (0.1) 7.7
Total other expense, net (22.1) 1.4 (43.0) 1.4
Income from continuing operations before income taxes and equity in earnings/(losses) of equity method investees (44.0) (217.3) (97.4) (217.3)
Income taxes (16.2) 58.8 (36.1) 58.8
Equity in income/(losses) of equity method investees, net of taxes 86.9 (130.9) (39.9) (130.9)
Income from continuing operations, net of taxes 26.7 (289.4) (173.4) (289.4)
(Loss)/gain from discontinued operations, net of taxes 0.0 0.0 0.0 0.0
Net income/(loss) 26.7 (289.4) (173.4) (289.4)
Comprehensive income/(loss) 1,401.8 (475.6) 1,450.5 (475.6)
Non-Guarantor Non-Issuer Subsidiaries        
Revenues:        
Product sales 3,591.8 2,322.1 7,004.1 3,949.4
Royalties and other revenues 154.0 107.0 314.0 189.0
Total revenues 3,745.8 2,429.1 7,318.1 4,138.4
Costs and expenses:        
Cost of sales 1,108.7 778.1 2,434.5 1,026.7
Research and development 542.4 294.8 921.7 511.9
Selling, general and administrative 886.2 649.6 1,760.0 1,107.5
Amortization of acquired intangible assets 434.1 213.0 798.1 347.6
Integration and acquisition costs 166.1 151.2 251.9 242.3
Reorganization costs 13.6 11.0 19.1 14.3
Gain/(loss) on sale of product rights (4.8) 2.3 0.7 6.5
Total operating expenses 3,155.9 2,095.4 6,184.6 3,243.8
Operating income from continuing operations 589.9 333.7 1,133.5 894.6
Interest (expense)/income, net (94.0) (58.3) (186.9) (58.3)
Other income/(expense), net 1.3 (2.9) 5.3 (11.1)
Total other expense, net (92.7) (61.2) (181.6) (69.4)
Income from continuing operations before income taxes and equity in earnings/(losses) of equity method investees 497.2 272.5 951.9 825.2
Income taxes (4.5) 11.6 8.4 (77.0)
Equity in income/(losses) of equity method investees, net of taxes 4.3 (0.9) 3.5 (1.0)
Income from continuing operations, net of taxes 497.0 283.2 963.8 747.2
(Loss)/gain from discontinued operations, net of taxes (1.2) (248.7) 19.0 (239.2)
Net income/(loss) 495.8 34.5 982.8 508.0
Comprehensive income/(loss) 1,923.0 (191.1) 2,677.0 305.9
Non-Guarantor Subsidiaries of Baxalta Notes        
Revenues:        
Product sales 3,591.8 2,322.1 7,004.1 3,949.4
Royalties and other revenues 154.0 107.0 314.0 189.0
Total revenues 3,745.8 2,429.1 7,318.1 4,138.4
Costs and expenses:        
Cost of sales 1,108.7 778.1 2,434.5 1,026.7
Research and development 542.4 294.8 921.7 511.9
Selling, general and administrative 886.2 649.6 1,760.0 1,107.5
Amortization of acquired intangible assets 434.1 213.0 798.1 347.6
Integration and acquisition costs 166.1 151.2 251.9 242.3
Reorganization costs 13.6 11.0 19.1 14.3
Gain/(loss) on sale of product rights (4.8) 2.3 0.7 6.5
Total operating expenses 3,155.9 2,095.4 6,184.6 3,243.8
Operating income from continuing operations 589.9 333.7 1,133.5 894.6
Interest (expense)/income, net (87.9) (56.7) (175.4) (78.5)
Other income/(expense), net 1.3 (2.9) 5.3 (11.1)
Total other expense, net (86.6) (59.6) (170.1) (89.6)
Income from continuing operations before income taxes and equity in earnings/(losses) of equity method investees 503.3 274.1 963.4 805.0
Income taxes (7.4) 11.2 4.2 (71.9)
Equity in income/(losses) of equity method investees, net of taxes 4.3 (0.9) 3.5 (1.0)
Income from continuing operations, net of taxes 500.2 284.4 971.1 732.1
(Loss)/gain from discontinued operations, net of taxes (1.2) (248.7) 19.0 (239.2)
Net income/(loss) 499.0 35.7 990.1 492.9
Comprehensive income/(loss) $ 1,926.2 $ (189.9) $ 2,684.3 $ 290.8